There's something new to be learnt everyday as a Biomedical Scientist. This is a record of my continous professional development .
About Me
- Clare
- I'm a busy Mum and a Biomedical Scientist in Haematology. My particular interest is in blood cell morphology and parasitology, where I never stop learning.
Tuesday, 29 September 2020
COVID-19 and Haemostasis
https://www.werfen.com/uk/en/covid-19-and-implications-haemostasis-and-viscoelastic-testing
Read this article today produced by Werfen, which highlighted the effects of COVID-19 on haemostasis.
Haemostasis testing has become important in the management of these patients, particularly the severe cases. It discusses how D-Dimer, Prothrombin Time, platelet count and Fibrinogen are of particular use in hospital admissions.
COVID-19 causes the following changes in Haemostais tests.
It also discusses how D-Dimer, prothrombin time, platelet count and Fibrinogen are of particular use in determining hospital admissions.
It seems that all COVID-19 patients are treated with low molecular weight infractionated heparin to reduce the risk of thrombotic complications.
I'm a busy Mum and a Biomedical Scientist in Haematology.
My particular interest is in blood cell morphology and parasitology, where I never stop learning.
Subscribe to:
Post Comments (Atom)
-
Zini et al, 2012 I recently reviewed the ICSH recommend...
-
I asked a colleague who is very experienced in thrombophilia testing and interpretation, how I could improve my…er.....not so good knowled...
-
Reviewing the XbarM analysis parameters used in our laboratory XbarM control program and looking at whether the current parameters being mon...
No comments:
Post a Comment